Searched for
GLYCOMET GP
Pharma market in good health; lifestyle diseases may be risingThe other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the...- Amid pollution woes, Asthma drug demand drives pharma retail market growth in NovemberIndia's pharmaceutical retail market rebounded in November with double-digit growth, fueled by increased demand for dermatological, cardiac...
- Pharma market picks up pace, sees 10% value growth in NovIndia's pharmaceutical market rebounded in November with 9.9% value growth and 3.1% volume growth. Key therapy areas like cardiac, gastroin...
- At over 10 cr, India’s diabetic population is surging, yet the country lags behind in prescribing new medicinesPriya Rao experienced confusion and worry after fainting and receiving different diabetic medications from two doctors. The first doctor fo...
- Sales of Electral jump 26% in hottest April on recordIndia's pharma market took a dip in March after poor sales of respiratory and anti-infective therapies dropped post-winter. April saw the m...
- Pharma market grows 9.5% in JanuaryThe Indian pharmaceutical market (IPM) saw a robust growth of 9.5% in January with all major therapy areas recording double-digit growth. A...
- Indian pharma market grows over 9 per cent in DecemberAmong the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last mont...
- GSK's Augmentin is India's no.1 drug brandResearch firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood...
- Third wave reorders India's pharma sweepstakes, antibiotic Azithral becomes top-selling drugThe widely-used drug saw sales soar 20X during the third wave of the pandemic. It registered a 100% jump in January over the previous month...
- A multivitamin tops drug sales for the first time in October, overtakes diabetes drugsA 30-year-old brand manufactured by the little-known Apex Labs, Zincovit registered sales of Rs 50 crore during October, dethroning the lar...
- USV in talks with Novartis to buy Jalra Trademark for Rs. 200 CroreMumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal...
- Domestic pharma retail market grows 13% in JulyAnti-diabetic therapy dominated the pecking order with four of the top 10 brands, Galvus MET and Janumet being the other top grossers.
- Code for pharma firms to have more teethThe voluntary code, initially applicable till June 2015, has been given four extensions despite the department repeatedly admitting it wasn...
- Five diabetes drugs in top-10 selling list; overtakes anti-infective, antibiotic medsInsulin brand Human Mixtard, oral formulation Glycomet GP, insulin Lantus, oral formulations Galvus Met and Janumet are now in the top-sell...
- Gastrointestinal drug sales show highest incremental gain in a yearAnti-infective cough and cold medication still tops the chart, with sales totalling Rs 14,735 crore in the domestic organised retail market.
- Indian pharma market crosses Rs 1,00,000 crore mark: IMS HealthIn its monthly review of the local market, IMS Health said in its note titled Market Reflections that Indian companies took over three-four...
- Domestic pharma retail market tops Rs 90k croreThe robust growth in July was attributed to nine therapies having outgrown the pharma market, with the anti-diabetic market growing at 25.4...
- Anti-diabetic drug tops India's pharma salesIn a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation ...
Load More
